PL3229780T3 - Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka - Google Patents

Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka

Info

Publication number
PL3229780T3
PL3229780T3 PL15823780T PL15823780T PL3229780T3 PL 3229780 T3 PL3229780 T3 PL 3229780T3 PL 15823780 T PL15823780 T PL 15823780T PL 15823780 T PL15823780 T PL 15823780T PL 3229780 T3 PL3229780 T3 PL 3229780T3
Authority
PL
Poland
Prior art keywords
treatment
dry eye
eye syndrome
ophthalmic compositions
ophthalmic
Prior art date
Application number
PL15823780T
Other languages
English (en)
Inventor
Lucia Gelsomino
Original Assignee
Alfa Intes Ind Terapeutica Splendore S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Intes Ind Terapeutica Splendore S R L filed Critical Alfa Intes Ind Terapeutica Splendore S R L
Publication of PL3229780T3 publication Critical patent/PL3229780T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15823780T 2014-12-12 2015-12-11 Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka PL3229780T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20142126 2014-12-12
EP15823780.0A EP3229780B1 (en) 2014-12-12 2015-12-11 Ophthalmic compositions for use in the treatment of the dry eye syndrome
PCT/IB2015/059533 WO2016092513A1 (en) 2014-12-12 2015-12-11 Ophthalmic compositions for use in the treatment of the dry eye syndrome

Publications (1)

Publication Number Publication Date
PL3229780T3 true PL3229780T3 (pl) 2019-05-31

Family

ID=52463050

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15823780T PL3229780T3 (pl) 2014-12-12 2015-12-11 Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka

Country Status (7)

Country Link
EP (1) EP3229780B1 (pl)
DK (1) DK3229780T3 (pl)
ES (1) ES2712849T3 (pl)
PL (1) PL3229780T3 (pl)
PT (1) PT3229780T (pl)
TR (1) TR201819920T4 (pl)
WO (1) WO2016092513A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111372564B (zh) * 2017-11-21 2024-10-15 创盛桥康制药有限公司 用于治疗眼周分泌腺中或眼表上的异常发炎的组合物和方法
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
IT201900023142A1 (it) * 2019-12-05 2021-06-05 Sifi Spa Composizione topica oculare contenente metaboliti della fermentazione di lactobacillus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546469A (fr) 1965-09-07 1968-11-22 Merck & Co Inc Stérilisation de médicaments solides
GB1386864A (en) 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
ITRM20010438A1 (it) 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
US20050196370A1 (en) 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
WO2006073786A2 (en) 2004-12-30 2006-07-13 Bausch & Lomb Incorporated Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy

Also Published As

Publication number Publication date
ES2712849T3 (es) 2019-05-16
TR201819920T4 (tr) 2019-01-21
DK3229780T3 (en) 2019-03-18
WO2016092513A1 (en) 2016-06-16
PT3229780T (pt) 2019-02-27
EP3229780A1 (en) 2017-10-18
EP3229780B1 (en) 2018-11-28

Similar Documents

Publication Publication Date Title
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
SG10201707617VA (en) Ophthalmic composition
IL246791A0 (en) Compositions and methods for treating eye diseases
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
EP3213723A4 (en) Device for treating dry eye syndrome and strengthening eyesight
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
EP3215157B8 (en) Apilimod for use in the treatment of melanoma
PL3160464T3 (pl) 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych
PL3145511T3 (pl) Kompozycja do leczenia oka
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
PL3122349T3 (pl) Kompozycje do leczenia samotrawienia
IL253220A0 (en) Preparations and methods for the treatment of glaucoma
IL246855A0 (en) Materials for use in the treatment of retinitis
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
LT3110425T (lt) Nelaki oftalmologinė kompozicija, ypač sausų akių sindromui gydyti
PT3229780T (pt) Composições oftálmicas para utilização no tratamento da síndrome de olhos secos
HUE044801T2 (hu) Adelmidrol alkalmazása epitheliális mûködési zavarok kezelésében
SI3397270T1 (sl) Sestavki za uporabo pri zdravljenju hunterjevega sindroma
ZA201703701B (en) Ophthalmic composition
IL251590B (en) Ophthalmic preparations
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
GB201413538D0 (en) Ophthalmic compositions and uses thereof
GB201404391D0 (en) Novel compositions having use in therapy